These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26332908)

  • 1. Cerebral Vasospasm: A Review.
    Findlay JM; Nisar J; Darsaut T
    Can J Neurol Sci; 2016 Jan; 43(1):15-32. PubMed ID: 26332908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of cerebral vasospasm after subarachnoid hemorrhage--a review.
    Wu CT; Wong CS; Yeh CC; Borel CO
    Acta Anaesthesiol Taiwan; 2004 Dec; 42(4):215-22. PubMed ID: 15679131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasospasm in aneurysmal subarachnoid hemorrhage: diagnosis, prevention, and management.
    Janardhan V; Biondi A; Riina HA; Sanelli PC; Stieg PE; Gobin YP
    Neuroimaging Clin N Am; 2006 Aug; 16(3):483-96, viii-ix. PubMed ID: 16935712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protective measures against cerebral ischemia following subarachnoid hemorrhage: Part 1].
    Romero Kräuchi O; Verger Bennasar AM
    Rev Esp Anestesiol Reanim; 2011 Apr; 58(4):230-5. PubMed ID: 21608279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage.
    Keyrouz SG; Diringer MN
    Crit Care; 2007; 11(4):220. PubMed ID: 17705883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nimodipine for the prevention of cerebral vasospasm after subarachnoid hemorrhage in 12 children.
    Heffren J; McIntosh AM; Reiter PD
    Pediatr Neurol; 2015 Mar; 52(3):356-60. PubMed ID: 25585913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study.
    Vajkoczy P; Meyer B; Weidauer S; Raabe A; Thome C; Ringel F; Breu V; Schmiedek P
    J Neurosurg; 2005 Jul; 103(1):9-17. PubMed ID: 16121967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Perspectives in the treatment of subarachnoid-hemorrhage-induced cerebral vasospasm].
    Fandino J; Fathi AR; Graupner T; Jacob S; Landolt H
    Neurocirugia (Astur); 2007 Feb; 18(1):16-27. PubMed ID: 17393042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral angioplasty using the Scepter XC dual lumen balloon for the treatment of vasospasm following intracranial aneurysm rupture.
    Heit JJ; Choudhri O; Marks MP; Dodd RL; Do HM
    J Neurointerv Surg; 2015 Jan; 7(1):56-61. PubMed ID: 24385556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clazosentan: prevention of cerebral vasospasm and the potential to overcome infarction.
    Beck J; Raabe A
    Acta Neurochir Suppl; 2011; 110(Pt 2):147-50. PubMed ID: 21125461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution.
    Macdonald RL; Pluta RM; Zhang JH
    Nat Clin Pract Neurol; 2007 May; 3(5):256-63. PubMed ID: 17479073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic treatments of the vasospasm].
    Tavernier B; Decamps F; Vega E; Poidevin P; Verdin M; Riegel B
    Ann Fr Anesth Reanim; 2007 Nov; 26(11):980-4. PubMed ID: 17933488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral vasospasm.
    Baggott CD; Aagaard-Kienitz B
    Neurosurg Clin N Am; 2014 Jul; 25(3):497-528. PubMed ID: 24994087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting and treating microvascular ischemia after subarachnoid hemorrhage.
    Sakowitz OW; Unterberg AW
    Curr Opin Crit Care; 2006 Apr; 12(2):103-11. PubMed ID: 16543784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cerebral vasospasm after subarachnoid hemorrhage. Current possibilities of prevention and treatment].
    Stachura K; Danilewicz B
    Przegl Lek; 2002; 59(1):46-8. PubMed ID: 12108047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker Discovery in Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage.
    Przybycien-Szymanska MM; Ashley WW
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1453-64. PubMed ID: 25957908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial.
    Macdonald RL; Kassell NF; Mayer S; Ruefenacht D; Schmiedek P; Weidauer S; Frey A; Roux S; Pasqualin A;
    Stroke; 2008 Nov; 39(11):3015-21. PubMed ID: 18688013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral vasospasm after subarachnoid hemorrhage.
    Janjua N; Mayer SA
    Curr Opin Crit Care; 2003 Apr; 9(2):113-9. PubMed ID: 12657973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm.
    Hänggi D; Eicker S; Beseoglu K; Behr J; Turowski B; Steiger HJ
    Cent Eur Neurosurg; 2009 May; 70(2):61-7. PubMed ID: 19711257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.